Anti-Citrate synthetase antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | Citrate synthetase |
| Immunogen: | Recombinant protein |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:100-1:1000); Immunohistochemistry (1:50-1:100); Flow Cytometry (1:50-1:200) |
| Reactivity: | Human, Mouse, Rat |
| Clonality (clone number): | Monoclonal (JU80-30) |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1% BSA, 40% glycerol, 0.05% NaN3. |
| Concentration: | 1mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | CISY_HUMAN antibody |
| Citrate synthase antibody | |
| Citrate synthase, mitochondrial antibody | |
| citrate synthetase antibody | |
| Cs antibody | |
| EC 2.3.3 antibody | |
| EC 2.3.3.1 antibody |
Show More
Target information
Transcription factor that recognizes and binds to the enhancer heptamer motif 5′-TGA[CG]TCA-3′ (PubMed:10995748, PubMed:22083952). Promotes activity of NR5A1 when phosphorylated by HIPK3 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation (PubMed:17210646). Involved in activated KRAS-mediated transcriptional activation of USP28 in colorectal cancer (CRC) cells (PubMed:24623306). Binds to the USP28 promoter in colorectal cancer (CRC) cells (PubMed:24623306).
Provider
Erpantech Laboratory